A detailed history of ETF Store, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, ETF Store, Inc. holds 4,287 shares of BMY stock, worth $247,617. This represents 0.23% of its overall portfolio holdings.

Number of Shares
4,287
Holding current value
$247,617
% of portfolio
0.23%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$39.66 - $51.75 $170,022 - $221,852
4,287 New
4,287 $221,000
Q3 2023

Oct 25, 2023

BUY
$57.89 - $64.73 $218,939 - $244,808
3,782 New
3,782 $219,000
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $958 - $1,135
14 Added 0.48%
2,938 $211,000
Q3 2022

Nov 02, 2022

BUY
$0.13 - $76.84 $1 - $691
9 Added 0.31%
2,924 $208,000
Q2 2022

Aug 02, 2022

BUY
$72.62 - $79.98 $653 - $719
9 Added 0.31%
2,915 $221,000
Q1 2022

May 04, 2022

BUY
$61.48 - $73.72 $178,660 - $214,230
2,906 New
2,906 $220,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track ETF Store, Inc. Portfolio

Follow ETF Store, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Store, Inc., based on Form 13F filings with the SEC.

News

Stay updated on ETF Store, Inc. with notifications on news.